Procter & Gamble Health Ltd - 500126 - Compliance Certificate As Per Reg. 7(3) Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 For The Quarter Ended June 30, 2019
With reference to the above, we are enclosing herewith compliance certificate as per Regulation 7(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 for the quarter ended June 30, 2019. Procter & Gamble Health Ltd - 500126 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
We have been informed by the shareholder, about the loss /misplacement of the share certificate as detailed in the attachment. Procter & Gamble Health Ltd - 500126 - Statement Of Investor Complaints For The Quarter Ended June 2019
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0440 Name of the Signatory :- Jeevan MondkarDesignation :- Company Secretary and Compliance Officer Procter & Gamble Health Ltd - 500126 - Shareholding for the Period Ended June 30, 2019
Procter & Gamble Health Ltd has submitted to BSE the Shareholding Pattern for the Period Ended June 30, 2019. For more details, kindly Click here Procter & Gamble Health Ltd - 500126 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
We have been informed by the shareholder, about the loss /misplacement of the share certificate as detailed in the attachment. Procter & Gamble Health Ltd - 500126 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
We have been informed by our Registrars and Share Transfer Agents, Karvy Fintech Private Limited about the issue of duplicate Share certificates to the shareholders mentioned in the attachment. Procter & Gamble Health Ltd - 500126 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
We have been informed by following shareholders, about the loss /misplacement of the share certificate as detailed in the attachment. Procter & Gamble Health Ltd - 500126 - Announcement under Regulation 30 (LODR)-Change in Directorate
We refer to our letter dated June 27, 2019, informing that Mr. Sujay Wasan had been appointed as an Additional (Non-Executive) Director of the Company subject to and effective from date of allotment of Director Identification Number. We would like to inform you that Mr. Sujay Wasan has been allotted DIN 08497942 by the Ministry of Corporate Affairs on July 1, 2019. Consequently, Mr. Sujay Wasan's appointment as an Additional Director (Non-Executive) is effective from July 1, 2019. Procter & Gamble Health Ltd - 500126 - Announcement under Regulation 30 (LODR)-Change in Directorate
We refer to our letter dated June 27, 2019, informing that Mr. Sujay Wasan had been appointed as an Additional (Non-Executive) Director of the Company subject to and effective from date of allotment of Director Identification Number. We would like to inform you that Mr. Sujay Wasan has been allotted DIN 08497942 by the Ministry of Corporate Affairs on July 1, 2019. Consequently, Mr. Sujay Wasan's appointment as an Additional Director (Non-Executive) is effective from July 1, 2019. Procter & Gamble Health Ltd - 500126 - Submission Of Application To The Stock Exchanges For Re-Classification Of Status From Promoter To Public
We hereby inform you that the Company has submitted applications to the Stock Exchange(s) viz., National Stock Exchange of India Limited and BSE Limited for re-classifying status of Emedia Export Company mit beschrankter Haftung, Chemitra Gesellschaft mit beschrankter Haftung and Merck Internationale Beteiligungen GmbH from promoter to public on June 28, 2019.